Clinical infection medicine
1 – 10 of 88
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Decreased prevalence of Moraxella catarrhalis in addition to Streptococcus pneumoniae in children with upper respiratory tract infection after introduction of conjugated pneumococcal vaccine : a retrospective cohort study
Littorin, N. LU ; Rünow, E. LU ; Ahl, J. LU ; Resman, F. LU and Riesbeck, K. LU
(2021)
In Clinical Microbiology and Infection
27(4).
p.1-630
Mark
-
A Stronger Innate Immune Response During Hyperacute HIV-1 Infection is associated with ACUTE retroviral syndrome
Hassan, Amin S LU ; Hare, Jonathan ; Gounder, Kamini ; Nazziwa, Jamirah LU
; Karlson, Sara
LU
; Olsson, Linnéa
; Streatfield, Claire
; Kamali, Anatoli
; Karita, Etienne
and Kilembe, William
, et al.
(2021)
In Clinical Infectious Diseases
Mark
- COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
-
Associations between Plasma HIV RNA Levels and Incidence of Invasive Cancer in People with HIV after Initiation of Combination Antiretroviral Therapy
Elvstam, Olof LU
; Marrone, Gaetano
; Medstrand, Patrik
LU
; Treutiger, Carl-Johan
; Svedhem, Veronica
; Gisslén, Magnus
and Björkman, Per
LU
(2021)
In Open Forum Infectious Diseases
Mark
- Low-level HIV viremia during antiretroviral therapy
- Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection
- Detection of Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic tuberculosis contacts : an observational study
- Capnocytophaga canimorsus tricuspid valve endocarditis
- Hepatitis C elimination in Sweden : Progress, challenges and opportunities for growth in the time of COVID-19
- Mortality among amphetamine users with hepatitis C virus infection : A nationwide study